
Sign up to save your podcasts
Or
Apple and Netflix both having strong weeks as the stocks trade near record highs. What’s next for the names and what could their rise mean for the rest of the markets? Plus long-struggling Gilead getting a boost today on early results of its experimental obesity pill. Can it effectively compete with the likes of Eli Lilly and Novo Nordisk?
Fast Money Disclaimer
3.9
12371,237 ratings
Apple and Netflix both having strong weeks as the stocks trade near record highs. What’s next for the names and what could their rise mean for the rest of the markets? Plus long-struggling Gilead getting a boost today on early results of its experimental obesity pill. Can it effectively compete with the likes of Eli Lilly and Novo Nordisk?
Fast Money Disclaimer
4,077 Listeners
494 Listeners
238 Listeners
3,180 Listeners
147 Listeners
327 Listeners
67 Listeners
153 Listeners
2,134 Listeners
2,073 Listeners
601 Listeners
545 Listeners
20 Listeners
200 Listeners
407 Listeners
302 Listeners
115 Listeners
806 Listeners
181 Listeners
60 Listeners
155 Listeners
22 Listeners
34 Listeners
16 Listeners
9 Listeners
276 Listeners
15 Listeners